138 related articles for article (PubMed ID: 36225644)
1. CircMYH9 increases KPNA2 mRNA stability to promote hepatocellular carcinoma progression in an EIF4A3-dependent manner.
Xia J; Wu C; Tang Y; Tang J; Zhu D; Zhang F; Xu Z; Sun D; Tan Z; Zhuo H
Am J Cancer Res; 2022; 12(9):4361-4372. PubMed ID: 36225644
[TBL] [Abstract][Full Text] [Related]
2. Karyopherin subunit-α 2 expression accelerates cell cycle progression by upregulating CCNB2 and CDK1 in hepatocellular carcinoma.
Gao CL; Wang GW; Yang GQ; Yang H; Zhuang L
Oncol Lett; 2018 Mar; 15(3):2815-2820. PubMed ID: 29435009
[TBL] [Abstract][Full Text] [Related]
3. Long non-coding RNA HAGLROS facilitates tumorigenesis and progression in hepatocellular carcinoma by sponging miR-26b-5p to up-regulate karyopherin α2 (KPNA2) and inactivate p53 signaling.
Tang G; Zhao H; Xie Z; Wei S; Chen G
Bioengineered; 2022 Mar; 13(3):7829-7846. PubMed ID: 35291921
[TBL] [Abstract][Full Text] [Related]
4. MicroRNA-139 inhibits hepatocellular carcinoma cell growth through down-regulating karyopherin alpha 2.
Zan Y; Wang B; Liang L; Deng Y; Tian T; Dai Z; Dong L
J Exp Clin Cancer Res; 2019 May; 38(1):182. PubMed ID: 31046781
[TBL] [Abstract][Full Text] [Related]
5. CircMYH9 drives colorectal cancer growth by regulating serine metabolism and redox homeostasis in a p53-dependent manner.
Liu X; Liu Y; Liu Z; Lin C; Meng F; Xu L; Zhang X; Zhang C; Zhang P; Gong S; Wu N; Ren Z; Song J; Zhang Y
Mol Cancer; 2021 Sep; 20(1):114. PubMed ID: 34496888
[TBL] [Abstract][Full Text] [Related]
6. Upregulated KPNA2 promotes hepatocellular carcinoma progression and indicates prognostic significance across human cancer types.
Guo X; Wang Z; Zhang J; Xu Q; Hou G; Yang Y; Dong C; Liu G; Liang C; Liu L; Zhou W; Liu H
Acta Biochim Biophys Sin (Shanghai); 2019 Mar; 51(3):285-292. PubMed ID: 30883648
[TBL] [Abstract][Full Text] [Related]
7. Karyopherin α2-dependent import of E2F1 and TFDP1 maintains protumorigenic stathmin expression in liver cancer.
Drucker E; Holzer K; Pusch S; Winkler J; Calvisi DF; Eiteneuer E; Herpel E; Goeppert B; Roessler S; Ori A; Schirmacher P; Breuhahn K; Singer S
Cell Commun Signal; 2019 Nov; 17(1):159. PubMed ID: 31783876
[TBL] [Abstract][Full Text] [Related]
8. Circ_0072995 Promotes Proliferation and Invasion via Regulating miR-1253/EIF4A3 Signaling in HCC.
He Q; Tao L; Xu H; Xie X; Cheng S
Cancer Manag Res; 2021; 13():5981-5987. PubMed ID: 34377018
[TBL] [Abstract][Full Text] [Related]
9. Long noncoding RNA CASC11 promotes hepatocarcinogenesis and HCC progression through EIF4A3-mediated E2F1 activation.
Song H; Liu Y; Li X; Chen S; Xie R; Chen D; Gao H; Wang G; Cai B; Yang X
Clin Transl Med; 2020 Nov; 10(7):e220. PubMed ID: 33252856
[TBL] [Abstract][Full Text] [Related]
10. Aberrant expression of nuclear KPNA2 is correlated with early recurrence and poor prognosis in patients with small hepatocellular carcinoma after hepatectomy.
Jiang P; Tang Y; He L; Tang H; Liang M; Mai C; Hu L; Hong J
Med Oncol; 2014 Aug; 31(8):131. PubMed ID: 25031071
[TBL] [Abstract][Full Text] [Related]
11. KPNA2-Associated Immune Analyses Highlight the Dysregulation and Prognostic Effects of GRB2, NRAS, and Their RNA-Binding Proteins in Hepatocellular Carcinoma.
Zhang X; Zhang J; Gao F; Fan S; Dai L; Zhang J
Front Genet; 2020; 11():593273. PubMed ID: 33193737
[TBL] [Abstract][Full Text] [Related]
12. The role of KPNA2 as a monotonically changing differentially expressed gene in the diagnosis, risk stratification, and chemotherapy sensitivity of chronic hepatitis B-liver cirrhosis-hepatocellular carcinoma.
Pan Y; Zhang Y; Lu Z; Jin D; Li S
J Cancer Res Clin Oncol; 2023 Nov; 149(15):13753-13771. PubMed ID: 37526663
[TBL] [Abstract][Full Text] [Related]
13. hsa_circ_0068631 promotes breast cancer progression through c-Myc by binding to EIF4A3.
Wang X; Chen M; Fang L
Mol Ther Nucleic Acids; 2021 Dec; 26():122-134. PubMed ID: 34513299
[TBL] [Abstract][Full Text] [Related]
14. Pleomorphic adenoma gene 1 mediates the role of karyopherin alpha 2 and has prognostic significance in hepatocellular carcinoma.
Hu ZY; Yuan SX; Yang Y; Zhou WP; Jiang H
J Exp Clin Cancer Res; 2014 Jul; 33(1):61. PubMed ID: 25060425
[TBL] [Abstract][Full Text] [Related]
15. MicroRNA‑875‑5p inhibits tumor growth and metastasis of hepatocellular carcinoma by targeting eukaryotic translation initiation factor 3 subunit a.
Chen T; Sun L; Yao B; Wang L; Wang Y; Niu Y; Liu R; Mo H; Liu Z; Tu K; Liu Q
Oncol Rep; 2020 Nov; 44(5):2067-2079. PubMed ID: 33000235
[TBL] [Abstract][Full Text] [Related]
16. Wip1 cooperates with KPNA2 to modulate the cell proliferation and migration of colorectal cancer via a p53-dependent manner.
Wang P; Zhao Y; Liu K; Liu X; Liang J; Zhou H; Wang Z; Zhou Z; Xu N
J Cell Biochem; 2019 Sep; 120(9):15709-15718. PubMed ID: 31127650
[TBL] [Abstract][Full Text] [Related]
17. EIF4A3-induced circTOLLIP promotes the progression of hepatocellular carcinoma via the miR-516a-5p/PBX3/EMT pathway.
Liu Y; Song J; Zhang H; Liao Z; Liu F; Su C; Wang W; Han M; Zhang L; Zhu H; Zhang Z; Liang H; Zhang L; Zhang B; Chen X
J Exp Clin Cancer Res; 2022 May; 41(1):164. PubMed ID: 35509064
[TBL] [Abstract][Full Text] [Related]
18. Multiomics-based analyses of KPNA2 highlight its multiple potentials in hepatocellular carcinoma.
Zhang J; Zhang X; Wang L; Kang C; Li N; Xiao Z; Dai L
PeerJ; 2021; 9():e12197. PubMed ID: 34616632
[TBL] [Abstract][Full Text] [Related]
19. Quantitative proteomics reveals regulation of karyopherin subunit alpha-2 (KPNA2) and its potential novel cargo proteins in nonsmall cell lung cancer.
Wang CI; Chien KY; Wang CL; Liu HP; Cheng CC; Chang YS; Yu JS; Yu CJ
Mol Cell Proteomics; 2012 Nov; 11(11):1105-22. PubMed ID: 22843992
[TBL] [Abstract][Full Text] [Related]
20. CircETFA upregulates CCL5 by sponging miR-612 and recruiting EIF4A3 to promote hepatocellular carcinoma.
Lu C; Rong D; Hui B; He X; Jiang W; Xu Y; Cao H; Xu Z; Tang W
Cell Death Discov; 2021 Oct; 7(1):321. PubMed ID: 34716323
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
